Glucagon-like peptide 1 (GLP-1, 7-36) molecule — a potent antihyperglycemic hormone, neuropeptide, and incretin. Research letter: Hematologic Cancers Among Patients With Type 2 Diabetes ...

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

GLP-1 receptor agonist use was also associated with an increased risk for suicidality compared with SGLT-2 inhibitor use ...

Initial reports of increased suicidality in GLP-1 RA users compared with the general population raised concerns about the risk for this rare but serious adverse event, given the rising popularity ...

At 5 years of follow-up, significantly fewer GLP-1 drug users (7.5%) than nonusers (12.2% ... subhazard ratio [aSHR] = 0.51; 95% CI, 0.36-0.71). In addition, at 5 years, significantly fewer ...

By Tarun Sai Lomte Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing ...